FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280538081> ?p ?o ?g. }

• W4280538081 abstract "Abstract Background The number of SPECT/CT time-points is important for accurate patient dose estimation in peptide receptor radionuclide therapy. However, it may be limited by the patient’s health and logistical reasons. Here, an image-based dosimetric workflow adapted to the number of SPECT/CT acquisitions available throughout the treatment cycles was proposed, taking into account patient-specific pharmacokinetics and usable in clinic for all organs at risk. Methods Thirteen patients with neuroendocrine tumors were treated with four injections of 7.4 GBq of $$^{177}$$ <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML> <mml:msup> <mml:mrow /> <mml:mn>177</mml:mn> </mml:msup> </mml:math> Lu-DOTATATE. Three SPECT/CT images were acquired during the first cycle (1H, 24H and 96H or 144H post-injection) and a single acquisition (24H) for following cycles. Absorbed doses were estimated for kidneys (LK and RK), liver (L), spleen (S), and three surrogates of bone marrow (L2 to L4, L1 to L5 and T9 to L5) that were compared. 3D dose rate distributions were computed with Monte Carlo simulations. Voxel dose rates were averaged at the organ level. The obtained Time Dose-Rate Curves (TDRC) were fitted with a tri-exponential model and time-integrated. This method modeled patient-specific uptake and clearance phases observed at cycle 1. Obtained fitting parameters were reused for the following cycles, scaled to the measure organ dose rate at 24H. An alternative methodology was proposed when some acquisitions were missing based on population average TDRC (named STP-Inter). Seven other patients with three SPECT/CT acquisitions at cycles 1 and 4 were included to estimate the uncertainty of the proposed methods. Results Absorbed doses (in Gy) per cycle available were: 3.1 ± 1.1 (LK), 3.4 ± 1.5 (RK), 4.5 ± 2.8 (L), 4.6 ± 1.8 (S), 0.3 ± 0.2 (bone marrow). There was a significant difference between bone marrow surrogates (L2 to L4 and L1 to L5, Wilcoxon’s test: p value < 0.05), and while depicting very doses, all three surrogates were significantly different than dose in background ( p value < 0.01). At cycle 1, if the acquisition at 24H is missing and approximated, medians of percentages of dose difference (PDD) compared to the initial tri-exponential function were inferior to 3.3% for all organs. For cycles with one acquisition, the median errors were smaller with a late time-point. For STP-Inter, medians of PDD were inferior to 7.7% for all volumes, but it was shown to depend on the homogeneity of TDRC. Conclusion The proposed workflow allows the estimation of organ doses, including bone marrow, from a variable number of time-points acquisitions for patients treated with $$^{177}$$ <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML> <mml:msup> <mml:mrow /> <mml:mn>177</mml:mn> </mml:msup> </mml:math> Lu-DOTATATE." @default.
• W4280538081 created "2022-05-22" @default.
• W4280538081 creator A5008844815 @default.
• W4280538081 creator A5027944578 @default.
• W4280538081 creator A5031016021 @default.
• W4280538081 creator A5053948279 @default.
• W4280538081 creator A5054644601 @default.
• W4280538081 creator A5065323896 @default.
• W4280538081 creator A5067966229 @default.
• W4280538081 creator A5085672955 @default.
• W4280538081 date "2022-05-16" @default.
• W4280538081 modified "2023-10-11" @default.
• W4280538081 title "Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for $$^{177}$$Lu-DOTATATE therapy" @default.
• W4280538081 cites W1964713829 @default.
• W4280538081 cites W1983680048 @default.
• W4280538081 cites W1983923913 @default.
• W4280538081 cites W2002849978 @default.
• W4280538081 cites W2016237506 @default.
• W4280538081 cites W2017460671 @default.
• W4280538081 cites W2017884723 @default.
• W4280538081 cites W2020961166 @default.
• W4280538081 cites W2027804252 @default.
• W4280538081 cites W2056268766 @default.
• W4280538081 cites W2062678527 @default.
• W4280538081 cites W2080043917 @default.
• W4280538081 cites W2089245409 @default.
• W4280538081 cites W2099478219 @default.
• W4280538081 cites W2148878903 @default.
• W4280538081 cites W2154289925 @default.
• W4280538081 cites W2175610922 @default.
• W4280538081 cites W2348973547 @default.
• W4280538081 cites W2408344295 @default.
• W4280538081 cites W2551923905 @default.
• W4280538081 cites W2573369749 @default.
• W4280538081 cites W2577784437 @default.
• W4280538081 cites W2599462151 @default.
• W4280538081 cites W2603187126 @default.
• W4280538081 cites W2622435004 @default.
• W4280538081 cites W2754110156 @default.
• W4280538081 cites W2789833205 @default.
• W4280538081 cites W2807307970 @default.
• W4280538081 cites W2811169451 @default.
• W4280538081 cites W2883658939 @default.
• W4280538081 cites W2903171994 @default.
• W4280538081 cites W2903288194 @default.
• W4280538081 cites W2939162307 @default.
• W4280538081 cites W2956355109 @default.
• W4280538081 cites W2956712082 @default.
• W4280538081 cites W2994281811 @default.
• W4280538081 cites W2999415756 @default.
• W4280538081 cites W3011631024 @default.
• W4280538081 cites W3013180133 @default.
• W4280538081 cites W3026889677 @default.
• W4280538081 cites W3028415628 @default.
• W4280538081 cites W3036540339 @default.
• W4280538081 cites W3047694216 @default.
• W4280538081 cites W3084849385 @default.
• W4280538081 cites W3090223225 @default.
• W4280538081 cites W3108279120 @default.
• W4280538081 cites W3111581306 @default.
• W4280538081 cites W3113319405 @default.
• W4280538081 cites W31940302 @default.
• W4280538081 doi "https://doi.org/10.1186/s40658-022-00462-2" @default.
• W4280538081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35575946" @default.
• W4280538081 hasPublicationYear "2022" @default.
• W4280538081 type Work @default.
• W4280538081 citedByCount "6" @default.
• W4280538081 countsByYear W42805380812022 @default.
• W4280538081 countsByYear W42805380812023 @default.
• W4280538081 crossrefType "journal-article" @default.
• W4280538081 hasAuthorship W4280538081A5008844815 @default.
• W4280538081 hasAuthorship W4280538081A5027944578 @default.
• W4280538081 hasAuthorship W4280538081A5031016021 @default.
• W4280538081 hasAuthorship W4280538081A5053948279 @default.
• W4280538081 hasAuthorship W4280538081A5054644601 @default.
• W4280538081 hasAuthorship W4280538081A5065323896 @default.
• W4280538081 hasAuthorship W4280538081A5067966229 @default.
• W4280538081 hasAuthorship W4280538081A5085672955 @default.
• W4280538081 hasBestOaLocation W42805380811 @default.
• W4280538081 hasConcept C11413529 @default.
• W4280538081 hasConcept C126838900 @default.
• W4280538081 hasConcept C201645570 @default.
• W4280538081 hasConcept C2908647359 @default.
• W4280538081 hasConcept C2989005 @default.
• W4280538081 hasConcept C2993559085 @default.
• W4280538081 hasConcept C33923547 @default.
• W4280538081 hasConcept C41008148 @default.
• W4280538081 hasConcept C509974204 @default.
• W4280538081 hasConcept C54170458 @default.
• W4280538081 hasConcept C71924100 @default.
• W4280538081 hasConcept C75088862 @default.
• W4280538081 hasConcept C99454951 @default.
• W4280538081 hasConceptScore W4280538081C11413529 @default.
• W4280538081 hasConceptScore W4280538081C126838900 @default.
• W4280538081 hasConceptScore W4280538081C201645570 @default.
• W4280538081 hasConceptScore W4280538081C2908647359 @default.
• W4280538081 hasConceptScore W4280538081C2989005 @default.
• W4280538081 hasConceptScore W4280538081C2993559085 @default.
• W4280538081 hasConceptScore W4280538081C33923547 @default.
• W4280538081 hasConceptScore W4280538081C41008148 @default.

• next